MedTrace Logo

Spanish Registry of Erythropoietic Stimulating Agents Study

NCT01739452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 722

Last updated 2018-08-13

No results posted yet for this study

Summary

Reviewing Spanish record of myelodysplastic syndromes (RESMD) data base in the group of patients with MDS. The information will be collected retrospectively from diagnosis of MDS, until the date of December 31, 2011.

Conditions

Sponsors & Collaborators

  • Grupo Español de Síndromes Mielodisplásicos

    lead OTHER

Principal Investigators

  • Maria Consuelo Cañizo, MD · University of Salamanca

  • María Díez, MD · University of Salamanca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-05-31
Completion
2014-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739452 on ClinicalTrials.gov